Cargando…
Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization
Complement activation plays a significant role in age-related macular degeneration (AMD) pathogenesis, and polymorphisms interfering with factor H (fH) function, a complement alternative pathway (AP) inhibitor, are associated with increased AMD risk. We have previously validated an AP inhibitor, a f...
Autores principales: | Schnabolk, Gloriane, Parsons, Nathaniel, Obert, Elisabeth, Annamalai, Balasubramaniam, Nasarre, Cecile, Tomlinson, Stephen, Lewin, Alfred S., Rohrer, Bärbel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723362/ https://www.ncbi.nlm.nih.gov/pubmed/29234687 http://dx.doi.org/10.1016/j.omtm.2017.11.003 |
Ejemplares similares
-
The use of Matrigel combined with encapsulated cell technology to deliver a complement inhibitor in a mouse model of choroidal neovascularization
por: Annamalai, Balasubramaniam, et al.
Publicado: (2020) -
Systemic Inflammation by Collagen-Induced Arthritis Affects the Progression of Age-Related Macular Degeneration Differently in Two Mouse Models of the Disease
por: Schnabolk, Gloriane, et al.
Publicado: (2020) -
Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model
por: Annamalai, Balasubramaniam, et al.
Publicado: (2018) -
Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells
por: Coughlin, Beth, et al.
Publicado: (2016) -
Dabigatran and Wet AMD, Results From Retinal Pigment Epithelial Cell Monolayers, the Mouse Model of Choroidal Neovascularization, and Patients From the Medicare Data Base
por: Akter, Tanjina, et al.
Publicado: (2022)